ABSTRACT
Avian coccidiosis is one of the serious infectious diseases that pose huge impact on the health and production of poultry, hence mainly controlled by regular use of prophylactic and therapeutic chemical drugs. Frequent use of anticoccidial drugs, however, has resulted in the development of resistance in the Eimeria species and concerns about drug residues which have stimulated the efforts to search for alternative. Aloe pulcherrima and Aloe debrana are some of the endemic Aloe species of Ethiopia which are traditionally used for the treatment of various infectious diseases. In this study, an in vitro trial was undertaken to evaluate the effect of Aloe debrana and A. pulcherrima leaf gel infusions on the inhibition of the sporulation of oocysts of mixed Eimeria species isolated from naturally infected chickens. In this assay, petri dishes containing unsporulated coccidian oocysts at a dose of 1500 oocysts/ml of fecal solution were randomly assigned to 10, 15, 25, and 30% w/v crude gel infusion of both aloe species in 1% potassium dichromate solution while Amprolium and distilled water served as control groups. The results of this study show that 10, 15, 25, and 3 0% w/v gel infusions at the tested concentrations have anticoccidial activity as evidenced by their ability to decrease significantly (P < 0.05) the sporulation of Eimeria oocysts relative to the control incubation. The efficacy of A. debrana was found significantly better (P < 0.05) than A. pulcherrima at different concentrations. However, A. debrana at 30% concentration showed significantly higher (P < 0.05) sporulation inhibition efficacy of 79.35% (CI: 75.99-83.21) compared to A. pulcherrima (69.17%, CI: 64.65-73.92) at similar concentration in relation to the control incubation, though this could not be compared to Amprolium which was more effective (P < 0.05) with an inhibition percentage of 90.54% (CI: 89.16-92.21). This study has shown that there is potential for use of Aloe debrana leaf gel for the control of avian coccidiosis and as a chemotherapeutic, though much research is needed to determine absolute concentration which will make it comparable to commercially available drugs in terms of efficacy.
ABSTRACT
This cross-sectional study was carried out to investigate the status of brucellosis in sheep management under extensive smallholder farming and intensively in governmental breeding ranches in six districts selected from three administrative zones. Using multistage sampling, serum samples of 2409 sheep from 274 flocks were collected and tested using the Rose Bengal Plate Agglutination Test (RBPT) and positive sera were confirmed using a Complement Fixation Test (CFT). Of all animals tested, 4.98% were RBPT positive, and after confirmation with CFT, the overall animal-level prevalence was found to be 4.89% (CI: 3.24-6.9%). Of the flocks sampled, 61 (22.3%, CI: 18.03-29.17%) had at least one animal positive to both tests. Significantly higher (P < 0.001) individual animal seroprevalence of 5.87% (CI: 3.83-7.31%) was found in sheep under smallholder production than in breeding ranches (1.75%, 95% CI: 1.57-3.05%). However, flock level seroprevalence in breeding ranches was found to be 100% (8/8), while in the smallholder production it was 19.92% (CI: 16.4-25.81%). Significantly highest animal-level seroprevalence of 9.55% (CI: 7.91-12.4%) was observed in north Wollo zone's smallholder farms. From the three studied breeding ranches, highest seroprevalence of 3.57% (CI: 2.84%-5.18%) was found in Sheno Agricultural Research Centre. Significantly higher seroprevalence (P < 0.01) was found in aborted sheep and with history of retained fetal membrane in both production systems. All the sheep flocks in the studied breeding ranches were found to be seropositive; hence, this study suggests strict control measures of ovine brucellosis in the breeding reaches, since they could be a source of infection for the smallholder farms.
ABSTRACT
A cross-sectional study was conducted in Chifra and Dewe districts of Afar region, Eastern Ethiopia, to determine the prevalence, agreement between diagnostic tests and host related risk factors of trypanosome infection in camel. An overall prevalence of 2%, 24.1%, 21.3%, 9.5% and 7.8% was recorded with respectively Giemsa stained thin blood smear, CATT/T. evansi, RoTat1.2 PCR, 18S PCR and ITS-1PCR in a cohort of 399 animals. Only one T. vivax infection was confirmed by TvPRAC PCR indicating T. evansi as the predominant species affecting camels in the study area. No single animal was positive when tested with T. evansi type B specific EVAB PCR. There was slight agreement between the CATT/T. evansi and the molecular tests. Among the PCR methods, RoTat 1.2 PCR yielded a significantly higher positivity rate compared to 18S PCR and ITS-1 PCR. There was no significant difference in the positivity rate observed in each gender of camels (p>0.05). The positivity rate was significantly higher in camels with poor body condition and in older animals when tested using the CATT/T.evansi or RoTat 1.2 PCR (p>0.05). Camels that tested positive with all tests had significantly lower PCV's (p<0.05). This study provides further evidence that T. evansi is endemic in the Afar region of Ethiopia. The latent class analysis indicated an estimate overall prevalence of 19% (95% CI: 13-28). Moreover, the model indicated low sensitivity of CATT/T. evansi (43%) and the PCR tests (39-53%) but higher specificity of the PCR tests (86-99%) and low specificity of CATT/T. evansi (80%). This study suggests that improved sensitivity and reliability of the tests would help diagnosis of trypanosomosis. Further studies are required to determine the prevalence of clinical disease and losses due to trypanosomosis.